The thesis
SilentDip is built on a tidy, testable idea: a sharp price drop that arrives without a negative headline is usually noise, and noise reverts. The same drop carrying real bad news tends to keep drifting lower. So the strategy only acts when two things line up — oversold technicals and an absence of salient negative sentiment — then exits as the name mean-reverts to its SMA20 or its RSI normalizes.
The logic draws on Clinch, He, Landsman & Li (SSRN working paper, Nov 2025), which extends Chan's classic 2003 work on how prices react to news versus no-news. It's a clean academic lineage, and the implementation stays faithful to it: this is a patient filter, not a dip-buying reflex.
Recent activity
Patience is the operative word. Across the last six scheduled runs (2 Nov – 6 Nov), SilentDip executed zero trades — no rejections either, simply no setups that cleared both gates. The only recent action was a single buy on 30 October: 2 shares of CAT at $622.54.
That leaves the live book overwhelmingly in cash ($8,740 of a ~$9,860 total). It also sits modestly below its $10k Season 2 starting line — down roughly 1.4% — with the daily total drifting between $9,858 and $9,984. Early days, tiny sample, but worth stating plainly rather than leaning only on the backtest.
Backtest and validation
Here the numbers are more impressive. Over 1,279 days the strategy returned 52.62% (final equity $15,262, ~8.7% CAGR), a Sharpe of 1.03, a 70.55% win rate across 294 trades, and a contained max drawdown of 10.38%.
More reassuring is the validation discipline. A 4-fold walk-forward test came back positive in all four folds, with the out-of-sample stretch (Jul 2025 – Oct 2026) returning 16.75% at a 1.91 Sharpe and just 2.39% drawdown. The Probabilistic Sharpe Ratio is a near-certain 0.991. Critically, the Deflated Sharpe Ratio — adjusted for 42 trials — is 0.563, which is the more honest figure: still positive, but a clear reminder that some of the headline edge is selection.
Strengths and risks
Strengths: a falsifiable thesis, low turnover-per-signal in practice, a high win rate, and — unusually — folds that strengthen over time (Sharpe climbs from 0.37 to 1.91 across the periods).
Risks: the two early folds (4.96% and 1.91%) carried most of the backtest's drawdown and barely any edge, so the glossy aggregate leans heavily on recent regimes. The DSR tempers the PSR. And the strategy's long cash idle means returns are lumpy and opportunity-dependent — it can do nothing for weeks. The live account being underwater, however slightly, is the honest counterweight to a flattering backtest.
Verdict: well-researched and well-validated, but prove it in the live tape before celebrating.